高剂量维生素D补充对体积骨密度和骨强度的影响:一项随机临床试验
这项为期3年的双盲随机临床试验在加拿大卡尔加里单中心纳入311名55至70岁无骨质疏松的健康成人,比较每日维生素D3 400 IU、4000 IU或10000 IU对桡骨和胫骨体积骨密度及骨强度的影响。结果显示,与400 IU组相比,4000 IU和10000 IU组桡骨体积骨密度显著降低,胫骨体积骨密度仅在10000 IU组显著降低,骨强度无显著差异。
要点
- 与每日400 IU相比,4000 IU和10000 IU组桡骨体积骨密度显著降低。
- 胫骨体积骨密度仅在10000 IU组较400 IU组显著降低。
- 桡骨和胫骨骨强度(失效载荷)变化无显著差异。
核心结论
- 在健康成人中,与每日400 IU相比,每日4000 IU或10000 IU维生素D治疗3年导致桡骨骨密度显著降低;胫骨骨密度仅在每日10000 IU剂量下显著降低;桡骨和胫骨骨强度无显著差异。
- 这些发现不支持高剂量维生素D补充对骨骼健康有益;需要进一步研究以确定其是否有害。
研究设计与样本
- 为期3年的双盲随机临床试验,在加拿大卡尔加里单中心进行,时间为2013年8月至2017年12月。
- 纳入311名社区居住的健康成人,无骨质疏松,年龄55至70岁,基线25-羟基维生素D(25[OH]D)水平为30至125 nmol/L。
- 干预为每日维生素D3 400 IU(n=109)、4000 IU(n=100)或10000 IU(n=102),持续3年;膳食摄入低于每日1200 mg的参与者补充钙。
- 共同主要结局为高分辨率外周定量计算机断层扫描评估的桡骨和胫骨总体积骨密度,以及有限元分析估计的桡骨和胫骨骨强度(失效载荷)。
主要发现
- 311名随机参与者中(53%为男性;平均[SD]年龄62.2[4.2]岁),287名(92%)完成研究。
- 基线、3个月和3年25(OH)D水平:400 IU组分别为76.3、76.7和77.4 nmol/L;4000 IU组分别为81.3、115.3和132.2 nmol/L;10000 IU组分别为78.4、188.0和144.4 nmol/L。
- 体积骨密度存在显著的组×时间交互作用。
- 试验结束时,与400 IU组相比,4000 IU组桡骨体积骨密度低-3.9 mg HA/cm3(95% CI,-6.5至-1.3),10000 IU组低-7.5 mg HA/cm3(95% CI,-10.1至-5.0);体积骨密度平均百分比变化分别为-1.2%(400 IU组)、-2.4%(4000 IU组)和-3.5%(10000 IU组)。
- 与400 IU组相比,胫骨体积骨密度差异在4000 IU组为-1.8 mg HA/cm3(95% CI,-3.7至0.1),在10000 IU组为-4.1 mg HA/cm3(95% CI,-6.0至-2.2);平均百分比变化分别为-0.4%(400 IU组)、-1.0%(4000 IU组)和-1.7%(10000 IU组)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Few studies have assessed the effects of daily vitamin D doses at or above the tolerable upper intake level for 12 months or greater, yet 3% of US adults report vitamin D intakes of at least 4000 IU per day. OBJECTIVE: To assess the dose-dependent effect of vitamin D supplementation on volumetric bone mineral density (BMD) and strength. DESIGN, SETTING, AND PARTICIPANTS: Three-year, double-blind, randomized clinical trial conducted in a single center in Calgary, Canada, from August 2013 to December 2017, including 311 community-dwelling healthy adults without osteoporosis, aged 55 to 70 years, with baseline levels of 25-hydroxyvitamin D (25[OH]D) of 30 to 125 nmol/L. INTERVENTIONS: Daily doses of vitamin D3 for 3 years at 400 IU (n = 109), 4000 IU (n = 100), or 10 000 IU (n = 102). Calcium supplementation was provided to participants with dietary intake of less than 1200 mg per day. MAIN OUTCOMES AND MEASURES: Co-primary outcomes were total volumetric BMD at radius and tibia, assessed with high resolution peripheral quantitative computed tomography, and bone strength (failure load) at radius and tibia estimated by finite element analysis. RESULTS: Of 311 participants who were randomized (53% men; mean [SD] age, 62.2 [4.2] years), 287 (92%) completed the study. Baseline, 3-month, and 3-year levels of 25(OH)D were 76.3, 76.7, and 77.4 nmol/L for the 400-IU group; 81.3, 115.3, and 132.2 for the 4000-IU group; and 78.4, 188.0, and 144.4 for the 10 000-IU group. There were significant group × time interactions for volumetric BMD. At trial end, radial volumetric BMD was lower for the 4000 IU group (-3.9 mg HA/cm3 [95% CI, -6.5 to -1.3]) and 10 000 IU group (-7.5 mg HA/cm3 [95% CI, -10.1 to -5.0]) compared with the 400 IU group with mean percent change in volumetric BMD of -1.2% (400 IU group), -2.4% (4000 IU group), and -3.5% (10 000 IU group). Tibial volumetric BMD differences from the 400 IU group were -1.8 mg HA/cm3 (95% CI, -3.7 to 0.1) in the 4000 IU group and -4.1 mg HA/cm3 in the 10 000 IU group (95% CI, -6.0 to -2.2), with mean percent change values of -0.4% (400 IU), -1.0% (4000 IU), and -1.7% (10 000 IU). There were no significant differences for changes in failure load (radius, P = .06; tibia, P = .12). CONCLUSIONS AND RELEVANCE: Among healthy adults, treatment with vitamin D for 3 years at a dose of 4000 IU per day or 10 000 IU per day, compared with 400 IU per day, resulted in statistically significant lower radial BMD; tibial BMD was significantly lower only with the 10 000 IU per day dose. There were no significant differences in bone strength at either the radius or tibia. These findings do not support a benefit of high-dose vitamin D supplementation for bone health; further research would be needed to determine whether it is harmful. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01900860.
引用
- Burt LA, Billington EO, Rose MS, et al. Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial. JAMA. 2019. PMID: 31454046. doi:10.1001/jama.2019.11889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。